Fas apoptosis inhibitory molecules: more than death-receptor antagonists in the nervous system

Journal of Neurochemistry

Volumn 139, Issue 1, 2016, Pages 11-21

  Planells Ferrer, Laura ^a,b,c   Urresti, Jorge ^a,b,c   Coccia, Elena ^a,b,c   Galenkamp, Koen M O ^a,b,c   Calleja Yagüe, Isabel ^a,b,c   López Soriano, Joaquín ^a,b,c   Carriba, Paulina ^a,b,c   Barneda Zahonero, Bruna ^a,b,c   Segura, Miguel F ^a   Comella, Joan X ^a,b,c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b INSTITUT DE NEUROCIÈNCIES   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

apoptosis; FAIM; lifeguard; nervous system; TOSO

Indexed keywords

CASPASE 3; CASPASE 8; FAIM1 PROTEIN; FAIM2 PROTEIN; FAIM3 PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN BCL 2; PROTEIN BCL XL; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS; APOPTOSIS REGULATORY PROTEIN; FAIM PROTEIN, HUMAN; FAS ANTIGEN;

3' UNTRANSLATED REGION; AMINO TERMINAL SEQUENCE; APOPTOSIS; CARBOXY TERMINAL SEQUENCE; ENZYME ACTIVATION; EXON SKIPPING; GENE EXPRESSION; HUMAN; LONG TERM DEPRESSION; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NERVOUS SYSTEM FUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL DEATH; DRUG EFFECTS; GENETICS; MOUSE; NERVOUS SYSTEM;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL DEATH; HUMANS; MICE; NERVOUS SYSTEM;

EID: 84980322344     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13729     Document Type: Review

References (101)

1. Aebischer J., Bernard-Marissal N., Pettmann B. and Raoul C. (2013) Death receptors in the selective degeneration of motoneurons in amyotrophic lateral sclerosis. J. Neurodegener. Dis. 2013, 746845.
2. Ashkenazi A. and Dixit V. M. (1999) Apoptosis control by death and decoy receptors. Curr. Opin. Cell Biol. 11, 255–260.
3. Beier C. P., Wischhusen J., Gleichmann M. et al. (2005) FasL (CD95L/APO-1L) resistance of neurons mediated by phosphatidylinositol 3-kinase-Akt/protein kinase B-dependent expression of lifeguard/neuronal membrane protein 35. J. Neurosci. 25, 6765–6774.
4. Bhaskar K., Maphis N., Xu G. et al. (2014) Microglial derived tumor necrosis factor-alpha drives Alzheimer's disease-related neuronal cell cycle events. Neurobiol. Dis. 62, 273–285.
5. Boehning D., Patterson R. L. and Snyder S. H. (2004) Apoptosis and calcium: new roles for cytochrome c and inositol 1,4,5-trisphosphate. Cell Cycle 3, 252–254.
6. Brenner D., Brustle A., Lin G. H. et al. (2014) Toso controls encephalitogenic immune responses by dendritic cells and regulatory T cells. Proc. Natl Acad. Sci. USA 111, 1060–1065.
7. Bucan V., Adili M. Y., Choi C. Y., Eddy M. T., Vogt P. M. and Reimers K. (2010a) Transactivation of lifeguard (LFG) by Akt-/LEF-1 pathway in MCF-7 and MDA-MB 231 human breast cancer cells. Apoptosis 15, 814–821.
8. Bucan V., Reimers K., Choi C. Y., Eddy M. T. and Vogt P. M. (2010b) The anti-apoptotic protein lifeguard is expressed in breast cancer cells and tissues. Cell. Mol. Biol. Lett. 15, 296–310.
9. Bucan V., Choi C. Y., Lazaridis A., Vogt P. M. and Reimers K. (2011) Silencing of anti-apoptotic transmembrane protein lifeguard sensitizes solid tumor cell lines MCF-7 and SW872 to perifosine-induced cell death activation. Oncol. Lett. 2, 419–422.
10. Cai J., Yang J. and Jones D. P. (1998) Mitochondrial control of apoptosis: the role of cytochrome c. Biochim. Biophys. Acta 1366, 139–149.
11. Carriba P. and Comella J. X. (2014) Amyloid beta, TNFalpha and FAIM-L; approaching new therapeutic strategies for AD. Front. Neurol. 5, 276.
12. Carriba P., Jimenez S., Navarro V. et al. (2015) Amyloid-beta reduces the expression of neuronal FAIM-L, thereby shifting the inflammatory response mediated by TNFalpha from neuronal protection to death. Cell Death Dis. 6, e1639.
13. Chae H. J., Kim H. R., Xu C. et al. (2004) BI-1 regulates an apoptosis pathway linked to endoplasmic reticulum stress. Mol. Cell 15, 355–366.
14. Chang Y., Bruni R., Kloss B., Assur Z., Kloppmann E., Rost B., Hendrickson W. A. and Liu Q. (2014) Structural basis for a pH-sensitive calcium leak across membranes. Science 344, 1131–1135.
15. Cohen P. L. and Eisenberg R. A. (1992) The lpr and gld genes in systemic autoimmunity: life and death in the Fas lane. Immunol. Today 13, 427–428.
16. Cusack C. L., Swahari V., Hampton Henley W., Michael Ramsey J. and Deshmukh M. (2013) Distinct pathways mediate axon degeneration during apoptosis and axon-specific pruning. Nat. Commun. 4, 1876.
17. Dastagir N., Lazaridis A., Dastagir K., Reimers K., Vogt P. M. and Bucan V. (2014) Role of Lifeguard beta-isoform in the development of breast cancer. Oncol. Rep. 32, 1335–1340.
18. Debatin K. M. and Krammer P. H. (2004) Death receptors in chemotherapy and cancer. Oncogene 23, 2950–2966.
19. Deppmann C. D., Mihalas S., Sharma N., Lonze B. E., Niebur E. and Ginty D. D. (2008) A model for neuronal competition during development. Science 320, 369–373.
20. Desbarats J., Birge R. B., Mimouni-Rongy M., Weinstein D. E., Palerme J. S. and Newell M. K. (2003) Fas engagement induces neurite growth through ERK activation and p35 upregulation. Nat. Cell Biol. 5, 118–125.
21. Eckelman B. P. and Salvesen G. S. (2006) The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. J. Biol. Chem. 281, 3254–3260.
22. Felderhoff-Mueser U., Taylor D. L., Greenwood K., Kozma M., Stibenz D., Joashi U. C., Edwards A. D. and Mehmet H. (2000) Fas/CD95/APO-1 can function as a death receptor for neuronal cells in vitro and in vivo and is upregulated following cerebral hypoxic-ischemic injury to the developing rat brain. Brain Pathol. 10, 17–29.
23. Fernandez M., Segura M. F., Sole C., Colino A., Comella J. X. and Cena V. (2007) Lifeguard/neuronal membrane protein 35 regulates Fas ligand-mediated apoptosis in neurons via microdomain recruitment. J. Neurochem. 103, 190–203.
24. French L. E. and Tschopp J. (2003) Protein-based therapeutic approaches targeting death receptors. Cell Death Differ. 10, 117–123.
25. Fulda S., Sieverts H., Friesen C., Herr I. and Debatin K. M. (1997) The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res. 57, 3823–3829.
26. Gavalda N., Gutierrez H. and Davies A. M. (2009) Developmental regulation of sensory neurite growth by the tumor necrosis factor superfamily member LIGHT. J. Neurosci. 29, 1599–1607.
27. Gehler S., Shaw A. E., Sarmiere P. D., Bamburg J. R. and Letourneau P. C. (2004) Brain-derived neurotrophic factor regulation of retinal growth cone filopodial dynamics is mediated through actin depolymerizing factor/cofilin. J. Neurosci. 24, 10741–10749.
28. Gibon J., Unsain N., Gamache K., Thomas R. A., De Leon A., Johnstone A., Nader K., Seguela P. and Barker P. A. (2016) The X-linked inhibitor of apoptosis regulates long-term depression and learning rate. FASEB J., 30, 1–8.
29. Guicciardi M. E. and Gores G. J. (2009) Life and death by death receptors. FASEB J. 23, 1625–1637.
30. Gumy L. F., Yeo G. S., Tung Y. C. et al. (2011) Transcriptome analysis of embryonic and adult sensory axons reveals changes in mRNA repertoire localization. RNA 17, 85–98.
31. Gutierrez H. and Davies A. M. (2011) Regulation of neural process growth, elaboration and structural plasticity by NF-kappaB. Trends Neurosci. 34, 316–325.
32. Gutierrez H., Kisiswa L., O'Keeffe G. W., Smithen M. J., Wyatt S. and Davies A. M. (2013) Regulation of neurite growth by tumour necrosis superfamily member RANKL. Open Biol. 3, 120150.
33. Hemond M., Rothstein T. L. and Wagner G. (2009) Fas apoptosis inhibitory molecule contains a novel beta-sandwich in contact with a partially ordered domain. J. Mol. Biol. 386, 1024–1037.
34. Heppner F. L., Ransohoff R. M. and Becher B. (2015) Immune attack: the role of inflammation in Alzheimer disease. Nat. Rev. Neurosci. 16, 358–372.
35. Hitoshi Y., Lorens J., Kitada S. I. et al. (1998) Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells. Immunity 8, 461–471.
36. Huo J., Xu S., Guo K., Zeng Q. and Lam K. P. (2009) Genetic deletion of faim reveals its role in modulating c-FLIP expression during CD95-mediated apoptosis of lymphocytes and hepatocytes. Cell Death Differ. 16, 1062–1070.
37. Huo J., Ma Y., Liu J. J. et al. (2016) Loss of Fas apoptosis inhibitory molecule leads to spontaneous obesity and hepatosteatosis. Cell Death Dis. 7, e2091.
38. Hurtado de Mendoza T., Perez-Garcia C. G., Kroll T. T., Hoong N. H., O'Leary D. D. and Verma I. M. (2011) Antiapoptotic protein Lifeguard is required for survival and maintenance of Purkinje and granular cells. Proc. Natl Acad. Sci. USA 108, 17189–17194.
39. Jiang S., Song M. J., Shin E. C., Lee M. O., Kim S. J. and Park J. H. (1999) Apoptosis in human hepatoma cell lines by chemotherapeutic drugs via Fas-dependent and Fas-independent pathways. Hepatology (Baltimore, MD) 29, 101–110.
40. Jost P. J., Grabow S., Gray D. et al. (2009) XIAP discriminates between type I and type II FAS-induced apoptosis. Nature 460, 1035–1039.
41. Keppler O. T., Peter M. E., Hinderlich S., Moldenhauer G., Stehling P., Schmitz I., Schwartz-Albiez R., Reutter W. and Pawlita M. (1999) Differential sialylation of cell surface glycoconjugates in a human B lymphoma cell line regulates susceptibility for CD95 (APO-1/Fas)-mediated apoptosis and for infection by a lymphotropic virus. Glycobiology 9, 557–569.
42. Kim J. H., Lee E. R., Jeon K. et al. (2012) Role of BI-1 (TEGT)-mediated ERK1/2 activation in mitochondria-mediated apoptosis and splenomegaly in BI-1 transgenic mice. Biochim. Biophys. Acta 1823, 876–888.
43. Kischkel F. C., Hellbardt S., Behrmann I., Germer M., Pawlita M., Krammer P. H. and Peter M. E. (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14, 5579–5588.
44. Kisiswa L., Osorio C., Erice C., Vizard T., Wyatt S. and Davies A. M. (2013) TNFalpha reverse signaling promotes sympathetic axon growth and target innervation. Nat. Neurosci. 16, 865–873.
45. Kong Y., Liang X., Liu L., Zhang D., Wan C., Gan Z. and Yuan L. (2015) High throughput sequencing identifies MicroRNAs mediating alpha-synuclein toxicity by targeting neuroactive-ligand receptor interaction pathway in early stage of Drosophila Parkinson's disease model. PLoS ONE 10, e0137432.
46. Lang K. S., Lang P. A., Meryk A. et al. (2013) Involvement of Toso in activation of monocytes, macrophages, and granulocytes. Proc. Natl Acad. Sci. USA 110, 2593–2598.
47. Li Z., Jo J., Jia J. M., Lo S. C., Whitcomb D. J., Jiao S., Cho K. and Sheng M. (2010) Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization. Cell 141, 859–871.
48. Li G., Qu L., Ma S., Wu Y., Jin C. and Zheng X. (2014) Structure determination of human Fas apoptosis inhibitory molecule and identification of the critical residues linking the interdomain interaction to the anti-apoptotic activity. Acta Crystallogr. D Biol. Crystallogr. 70, 1812–1822.
49. Lisak D. A., Schacht T., Enders V., Habicht J., Kiviluoto S., Schneider J., Henke N., Bultynck G. and Methner A. (2015) The transmembrane Bax inhibitor motif (TMBIM) containing protein family: tissue expression, intracellular localization and effects on the ER CA(2)(+)-filling state. Biochim. Biophys. Acta 1853, 2104–2114.
50. Marchetti D., Aucoin R., Blust J., Murry B. and Greiter-Wilke A. (2004) p75 neurotrophin receptor functions as a survival receptor in brain-metastatic melanoma cells. J. Cell. Biochem. 91, 206–215.
51. Marques-Fernandez F., Planells-Ferrer L., Gozzelino R. et al. (2013) TNFalpha induces survival through the FLIP-L-dependent activation of the MAPK/ERK pathway. Cell Death Dis. 4, e493.
52. Martin-Villalba A., Herr I., Jeremias I., Hahne M., Brandt R., Vogel J., Schenkel J., Herdegen T. and Debatin K. M. (1999) CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J. Neurosci. 19, 3809–3817.
53. McKelvey L., Gutierrez H., Nocentini G., Crampton S. J., Davies A. M., Riccardi C. R. and O'Keeffe G. W. (2012) The intracellular portion of GITR enhances NGF-promoted neurite growth through an inverse modulation of Erk and NF-kappaB signalling. Biol. Open 1, 1016–1023.
54. Merianda T. T., Vuppalanchi D., Yoo S., Blesch A. and Twiss J. L. (2013) Axonal transport of neural membrane protein 35 mRNA increases axon growth. J. Cell Sci. 126, 90–102.
55. Mignotte B. and Vayssiere J. L. (1998) Mitochondria and apoptosis. Eur. J. Biochem. 252, 1–15.
56. Minter M. R., Taylor J. M. and Crack P. J. (2016) The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease. J. Neurochem. 136, 457–474.
57. Moubarak R. S., Planells-Ferrer L., Urresti J. et al. (2013) FAIM-L is an IAP-binding protein that inhibits XIAP ubiquitinylation and protects from Fas-induced apoptosis. J. Neurosci. 33, 19262–19275.
58. Murakami Y., Narayanan S., Su S., Childs R., Krzewski K., Borrego F., Weck J. and Coligan J. E. (2012) Toso, a functional IgM receptor, is regulated by IL-2 in T and NK cells. J. Immunol., 189, 587–597.
59. Nguyen X. H., Lang P. A., Lang K. S. et al. (2011) Toso regulates the balance between apoptotic and nonapoptotic death receptor signaling by facilitating RIP1 ubiquitination. Blood 118, 598–608.
60. Nguyen X. H., Fattakhova G., Lang P. A., Lang K. S., Adam D., Foger N. and Lee K. H. (2012) Antiapoptotic function of Toso (Faim3) in death receptor signaling. Blood 119, 1790–1791.
61. Nolan A. M., Collins L. M., Wyatt S. L., Gutierrez H. and O'Keeffe G. W. (2014) The neurite growth inhibitory effects of soluble TNFalpha on developing sympathetic neurons are dependent on developmental age. Differentiation 88, 124–130.
62. Ofengeim D. and Yuan J. (2013) Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death. Nat. Rev. Mol. Cell Biol. 14, 727–736.
63. Pallasch C. P. and Wendtner C. M. (2009) Overexpression of the Fas-inhibitory molecule TOSO: a novel antiapoptotic factor in chronic lymphocytic leukemia. Leuk. Lymphoma 50, 498–501.
64. Pallasch C. P., Schulz A., Kutsch N. et al. (2008) Overexpression of TOSO in CLL is triggered by B-cell receptor signaling and associated with progressive disease. Blood 112, 4213–4219.
65. Patron J. P., Fendler A., Bild M. et al. (2012) MiR-133b targets antiapoptotic genes and enhances death receptor-induced apoptosis. PLoS ONE 7, e35345.
66. Pickering M., Cumiskey D. and O'Connor J. J. (2005) Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. Exp. Physiol. 90, 663–670.
67. Planells-Ferrer L., Urresti J., Soriano A. et al. (2014) MYCN repression of Lifeguard/FAIM2 enhances neuroblastoma aggressiveness. Cell Death Dis. 5, e1401.
68. Ponten F., Gry M., Fagerberg L. et al. (2009) A global view of protein expression in human cells, tissues, and organs. Mol. Syst. Biol. 5, 337.
69. Proto-Siqueira R., Panepucci R. A., Careta F. P. et al. (2008) SAGE analysis demonstrates increased expression of TOSO contributing to Fas-mediated resistance in CLL. Blood 112, 394–397.
70. Raj B., Irimia M., Braunschweig U. et al. (2014) A global regulatory mechanism for activating an exon network required for neurogenesis. Mol. Cell 56, 90–103.
71. Reich A., Spering C., Gertz K. et al. (2011) Fas/CD95 regulatory protein Faim2 is neuroprotective after transient brain ischemia. J. Neurosci. 31, 225–233.
72. Reimers K., Choi C. Y., Mau-Thek E. and Vogt P. M. (2006) Sequence analysis shows that Lifeguard belongs to a new evolutionarily conserved cytoprotective family. Int. J. Mol. Med. 18, 729–734.
73. Richards R. I., Robertson S. A., O'Keefe L. V., Fornarino D., Scott A., Lardelli M. and Baune B. T. (2016) The enemy within: innate surveillance-mediated cell death, the common mechanism of neurodegenerative disease. Front. Neurosci. 10, 193.
74. Rojas-Rivera D. and Hetz C. (2015) TMBIM protein family: ancestral regulators of cell death. Oncogene 34, 269–280.
75. Sano R., Hou Y. C., Hedvat M. et al. (2012) Endoplasmic reticulum protein BI-1 regulates Ca(2)(+)-mediated bioenergetics to promote autophagy. Genes Dev. 26, 1041–1054.
76. Schneider T. J., Fischer G. M., Donohoe T. J., Colarusso T. P. and Rothstein T. L. (1999) A novel gene coding for a Fas apoptosis inhibitory molecule (FAIM) isolated from inducibly Fas-resistant B lymphocytes. J. Exp. Med. 189, 949–956.
77. Schweitzer B., Taylor V., Welcher A. A., McClelland M. and Suter U. (1998) Neural membrane protein 35 (NMP35): a novel member of a gene family which is highly expressed in the adult nervous system. Mol. Cell Neurosci. 11, 260–273.
78. Schweitzer B., Suter U. and Taylor V. (2002) Neural membrane protein 35/Lifeguard is localized at postsynaptic sites and in dendrites. Brain Res. Mol. Brain Res. 107, 47–56.
79. Segura M. F., Sole C., Pascual M. et al. (2007) The long form of Fas apoptotic inhibitory molecule is expressed specifically in neurons and protects them against death receptor-triggered apoptosis. J. Neurosci. 27, 11228–11241.
80. Sigruener A., Buechler C., Bared S. M., Grandl M., Aslanidis C., Ugocsai P., Gehrmann M. and Schmitz G. (2007) E-LDL upregulates TOSO expression and enhances the survival of human macrophages. Biochem. Biophys. Res. Commun. 359, 723–728.
81. Simon D. J., Weimer R. M., McLaughlin T., Kallop D., Stanger K., Yang J., O'Leary D. D. M., Hannoush R. N. and Tessier-Lavigne M. (2012) A caspase cascade regulating developmental axon degeneration. J. Neurosci. 32, 17540–17553.
82. Slee E. A., Harte M. T., Kluck R. M. et al. (1999) Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 144, 281–292.
83. Sole C., Dolcet X., Segura M. F. et al. (2004) The death receptor antagonist FAIM promotes neurite outgrowth by a mechanism that depends on ERK and NF-kapp B signaling. J. Cell Biol. 167, 479–492.
84. Somia N. V., Schmitt M. J., Vetter D. E., Van Antwerp D., Heinemann S. F. and Verma I. M. (1999) LFG: an anti-apoptotic gene that provides protection from Fas-mediated cell death. Proc. Natl Acad. Sci. USA 96, 12667–12672.
85. Song Y. and Jacob C. O. (2005) The mouse cell surface protein TOSO regulates Fas/Fas ligand-induced apoptosis through its binding to Fas-associated death domain. J. Biol. Chem. 280, 9618–9626.
86. Song J., Zhang Z., Hu W. and Chen Y. (2005) Small ubiquitin-like modifier (SUMO) recognition of a SUMO binding motif: a reversal of the bound orientation. J. Biol. Chem. 280, 40122–40129.
87. Srinivasula S. M. and Ashwell J. D. (2008) IAPs: what's in a name? Mol. Cell 30, 123–135.
88. Tauber S. C., Harms K., Falkenburger B., Weis J., Sellhaus B., Nau R., Schulz J. B. and Reich A. (2014) Modulation of hippocampal neuroplasticity by Fas/CD95 regulatory protein 2 (Faim2) in the course of bacterial meningitis. J. Neuropathol. Exp. Neurol. 73, 2–13.
89. Unsain N., Higgins J. M., Parker K. N., Johnstone A. D. and Barker P. A. (2013) XIAP regulates caspase activity in degenerating axons. Cell Rep. 4, 751–763.
90. Urresti J., Ruiz-Meana M., Coccia E. et al. (2016) Lifeguard inhibits Fas ligand-mediated endoplasmic reticulum-calcium release mandatory for apoptosis in type II apoptotic cells. J. Biol. Chem. 291, 1221–1234.
91. Vila M. and Przedborski S. (2003) Targeting programmed cell death in neurodegenerative diseases. Nat. Rev. Neurosci. 4, 365–375.
92. Vizard T. N., O'Keeffe G. W., Gutierrez H., Kos C. H., Riccardi D. and Davies A. M. (2008) Regulation of axonal and dendritic growth by the extracellular calcium-sensing receptor. Nat. Neurosci. 11, 285–291.
93. Wang B., Nguyen M., Breckenridge D. G., Stojanovic M., Clemons P. A., Kuppig S. and Shore G. C. (2003) Uncleaved BAP31 in association with A4 protein at the endoplasmic reticulum is an inhibitor of Fas-initiated release of cytochrome c from mitochondria. J. Biol. Chem. 278, 14461–14468.
94. Wheeler M. A., Heffner D. L., Kim S., Espy S. M., Spano A. J., Cleland C. L. and Deppmann C. D. (2014) TNF-alpha/TNFR1 signaling is required for the development and function of primary nociceptors. Neuron 82, 587–602.
95. White C., Li C., Yang J., Petrenko N. B., Madesh M., Thompson C. B. and Foskett J. K. (2005) The endoplasmic reticulum gateway to apoptosis by Bcl-X(L) modulation of the InsP3R. Nat. Cell Biol. 7, 1021–1028.
96. Willis D. E., van Niekerk E. A., Sasaki Y. et al. (2007) Extracellular stimuli specifically regulate localized levels of individual neuronal mRNAs. J. Cell Biol. 178, 965–980.
97. Wozniak A. L., Wang X., Stieren E. S., Scarbrough S. G., Elferink C. J. and Boehning D. (2006) Requirement of biphasic calcium release from the endoplasmic reticulum for Fas-mediated apoptosis. J. Cell Biol. 175, 709–714.
98. Yang Y., Fang S., Jensen J. P., Weissman A. M. and Ashwell J. D. (2000) Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 288, 874–877.
99. Yu L. Y., Saarma M. and Arumae U. (2008) Death receptors and caspases but not mitochondria are activated in the GDNF- or BDNF-deprived dopaminergic neurons. J. Neurosci. 28, 7467–7475.
100. Zhong X., Schneider T. J., Cabral D. S., Donohoe T. J. and Rothstein T. L. (2001) An alternatively spliced long form of Fas apoptosis inhibitory molecule (FAIM) with tissue-specific expression in the brain. Mol. Immunol. 38, 65–72.
101. Zuliani C., Kleber S., Klussmann S. et al. (2006) Control of neuronal branching by the death receptor CD95 (Fas/Apo-1). Cell Death Differ. 13, 31–40.